Jesse Veenstra
- Dermatology top 5%
- Cutaneous lymphoproliferative disorders research 6
- Hidradenitis Suppurativa and Treatments 5
- Chemotherapy-related skin toxicity 4
- Dermatology and Skin Diseases 4
-
- Immunotherapy and Immune Responses 5
-
- Cancer Immunotherapy and Biomarkers 5
- CAR-T cell therapy research 4
-
- Drug-Induced Adverse Reactions 4
- Co-authors
- David OzogQing‐Sheng MiHeather M. GibsonWei‐Zen WeiLi ZhouBen J. FriedmanPeter DimitrionMelody J. Eide
- Cited by
- DermatologyImmunologyOncology
- Journals
- Journal of the American Academy of Dermatology (7 papers)Journal of Investigative Dermatology (3 papers)British Journal of Dermatology (2 papers)
- Partner nations
- United StatesNetherlandsCanada
In The Last Decade
Jesse Veenstra
37 papers receiving 240 citations
Peers
Comparison fields: 5 of 57
- Dermatology 86
- Immunology 71
- Oncology 77
- Infectious Diseases 31
- Epidemiology 58
Countries citing papers authored by Jesse Veenstra
This map shows the geographic impact of Jesse Veenstra's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jesse Veenstra with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jesse Veenstra more than expected).
Fields of papers citing papers by Jesse Veenstra
This network shows the impact of papers produced by Jesse Veenstra. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jesse Veenstra. The network helps show where Jesse Veenstra may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Jesse Veenstra, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 2 | |
| 2 | 2025 | 0 | |
| 3 | 2024 | 2 | |
| 4 | 2024 | 1 | |
| 5 | 2023 | 3 | |
| 6 | 2023 | 4 | |
| 7 | 2023 | 2 | |
| 8 | 2023 | 3 | |
| 9 | 2022 | 18 | |
| 10 | 2022 | 8 | |
| 11 | 2021 | 27 | |
| 12 | 2021 | 2 | |
| 13 | 2021 | 18 | |
| 14 | 2020 | 0 | |
| 15 | 2020 | 17 | |
| 16 | 2015 | 11 | |
| 17 | 2015 | 11 | |
| 18 | 2015 | 15 | |
| 19 | 2015 | 5 | |
| 20 | 2014 | 20 |
About Jesse Veenstra
Jesse Veenstra is a scholar working on Dermatology, Toxicology and Immunology, having authored 42 papers that have together received 245 indexed citations. Recurring topics across this work include Cutaneous lymphoproliferative disorders research (6 papers), Hidradenitis Suppurativa and Treatments (5 papers), Immunotherapy and Immune Responses (5 papers), Cancer Immunotherapy and Biomarkers (5 papers), Drug-Induced Adverse Reactions (4 papers), Chemotherapy-related skin toxicity (4 papers), CAR-T cell therapy research (4 papers) and Dermatology and Skin Diseases (4 papers). The work is most often cited by research in Dermatology (86 citations), Immunology (71 citations) and Oncology (77 citations). Jesse Veenstra has collaborated with scholars based in United States, Netherlands and Canada. Frequent co-authors include David Ozog, Qing‐Sheng Mi, Heather M. Gibson, Wei‐Zen Wei, Li Zhou, Ben J. Friedman, Peter Dimitrion, Melody J. Eide, Peter J. Littrup and Aimin Jiang. Their work appears in journals such as Journal of the American Academy of Dermatology, Journal of Investigative Dermatology, British Journal of Dermatology, OncoImmunology and Orphanet Journal of Rare Diseases.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.